Center for biologics evaluation and research (CBER) requirement for their biologics effectiveness and safety (BEST) initiative: data, tools and infrastructure for surveillance of biologics
Ended Awarded Last action
- Contract number
- 75F40120F19003
- Awardee
-
International Business Machines Corporation UEI VV9KH3L99VE3 Part of International Business Machines Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $13,239,710
Award facts
- Opportunity
-
- FDA18223SOL1196209 Solicitation number
- Contract value 100% obligated
- $13,239,710.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Westlake, MD 20817, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $2,783,494 | |
| Exercise an Option | $5,146,594 | |
| Supplemental Agreement for work within scope | $297,780 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $5,011,841 |
About this award
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of biologics. Major subcontractors include the University of Florida, Eclaro International Inc., Medstar Health Research Institute, Accenture Federal Services LLC, Merative US L.P., Eight Eleven Group, LLC, Georgia Tech Applied Research Corporation, and Razr Solutions, LLC. Performance will take place in Westlake, Maryland over a three-year and six-month period from September 2020 through March 2024. The contract is being performed on a time-and-materials basis.
Quick answers
Who was awarded contract 75F40120F19003?
75F40120F19003 was awarded to International Business Machines Corporation by Food and Drug Administration (Department of Health and Human Services) on September 29, 2020.
How much is contract 75F40120F19003 worth?
The government has obligated $13,239,710 on 75F40120F19003.
Is contract 75F40120F19003 an order under another contract?
Yes. 75F40120F19003 is a delivery order under 75F40118D10022, an indefinite delivery contract, on BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics.
Was contract 75F40120F19003 competed?
The extent of competition for 75F40120F19003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award